Delivera™
A next-generation platform delivering multiple therapies precisely to the right tissue.
Delivera™
A next-generation platform delivering multiple therapies precisely to the right tissue.
We develop breakthrough delivery systems powering therapies across:
We develop breakthrough delivery systems powering therapies across:
We develop breakthrough delivery systems powering therapies across:
Oncology
We focus on ovarian, breast, colon, and lung cancers, developing targeted nanoparticles that deliver multiple therapies directly to tumors while sparing healthy tissue.
Oncology
We focus on ovarian, breast, colon, and lung cancers, developing targeted nanoparticles that deliver multiple therapies directly to tumors while sparing healthy tissue.
Oncology
We focus on ovarian, breast, colon, and lung cancers, developing targeted nanoparticles that deliver multiple therapies directly to tumors while sparing healthy tissue.
Genome Editing
Delivering base editors and CRISPR components directly to muscle cells to restore dystrophin expression and treat Duchenne muscular dystrophy (DMD).
Genome Editing
Delivering base editors and CRISPR components directly to muscle cells to restore dystrophin expression and treat Duchenne muscular dystrophy (DMD).
Genome Editing
Delivering base editors and CRISPR components directly to muscle cells to restore dystrophin expression and treat Duchenne muscular dystrophy (DMD).
Central Nervous System (CNS)
Using our targeted delivery nanoparticles to cross the blood–brain barrier and deliver therapies to the brain with a single intravenous injection.
Central Nervous System (CNS)
Using our targeted delivery nanoparticles to cross the blood–brain barrier and deliver therapies to the brain with a single intravenous injection.
Central Nervous System (CNS)
Using our targeted delivery nanoparticles to cross the blood–brain barrier and deliver therapies to the brain with a single intravenous injection.
